Galvani Bioelectronics

Galvani Bioelectronics is a new company, established in November 2016, dedicated to the development of bioelectronic medicines – a new class of medicines consisting of miniaturised, implantable devices.

Formed through a partnership between global healthcare company, GSK, and leading technology company, Verily Life Sciences, Galvani Bioelectronics combines the complementary expertise of its parent companies to enable the research, development and commercialization of bioelectronic therapies.

Bioelectronic medicine is an emerging scientific field, aiming to use tiny implantable devices to change precise electrical signals in nerves to treat a range of debilitating chronic diseases. Galvani Bioelectronics represents an important step change in the research and development of these medicines, combining GSK’s discovery and development expertise and deep understanding of disease biology with Verily’s world leading expertise in the miniaturisation of low power electronics, device development, data analytics and software development for clinical applications.

Spotlight
See all
Posted on Date:
Tuesday, December 5, 2017
Category: